EuBiologics Co (XKRX:206650) Beginning Cash Position : ₩22,854 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is EuBiologics Co Beginning Cash Position?

EuBiologics Co's Beginning Cash Position for the quarter that ended in Mar. 2025 was ₩22,854 Mil.

EuBiologics Co's quarterly Beginning Cash Position increased from Sep. 2024 (₩8,992 Mil) to Dec. 2024 (₩11,900 Mil) and increased from Dec. 2024 (₩11,900 Mil) to Mar. 2025 (₩22,854 Mil).

EuBiologics Co's annual Beginning Cash Position increased from Dec. 2022 (₩6,535 Mil) to Dec. 2023 (₩11,044 Mil) but then declined from Dec. 2023 (₩11,044 Mil) to Dec. 2024 (₩9,897 Mil).

EuBiologics Co Beginning Cash Position Historical Data

The historical data trend for EuBiologics Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EuBiologics Co Beginning Cash Position Chart

EuBiologics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

5,667.39

53,088.17

6,534.63

11,044.02

9,897.18

EuBiologics Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															9,897.18	14,463.03	8,992.34	11,899.53	22,854.17

EuBiologics Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

EuBiologics Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of EuBiologics Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

EuBiologics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EuBiologics Co Ltd (XKRX:206650) » Definitions » Beginning Cash Position

Traded in Other Exchanges

N/A

Address

6F Bomnal-A-Chim B/D Mabang-ro 8, Seocho-gu, Seoul, KOR, 06778

Website

http://www.eubiologics.com

EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

EuBiologics Co Headlines

No Headlines